Spots Global Cancer Trial Database for Allogeneic Tumor Cell Vaccination in Patients With Chronic Myeloid Leukemia
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Allogeneic Tumor Cell Vaccination in Patients With Chronic Myeloid Leukemia
Official Title: Allogeneic Tumor Cell Vaccination in Patients With Chronic Myeloid Leukemia
Study ID: NCT00162513
Conditions
Interventions
Study Description
Brief Summary: Donors with CM will be solicited from a waiting list of patients awaiting BMT from the waiting list of MUD searches. Maximally matched donor will be searched for each eligible CML patient with a goal in mind to find other patients with CML that share both class I and class II determinants. Sharing of one class I II will be considered eligible for participation in the study. Peripheral blood and PBMC from the donors will be isolated, washed and irradiated. The cells will be injected into the consenting patients intracutaneously at 2 weeks intervals for a total of 6 injections.
Detailed Description:
Keywords
Eligibility
Minimum Age: 55 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Hadassah Medical Organization, Jerusalem, , Israel
Contact Details
Name: Shimon Slavin, MD
Affiliation: Hadassah Medical Organization
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
